Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2013

Mar 27, 2013

30826_dirs_2013-03-27_82a36d03-2003-4e7f-b0c6-771097737956.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2013-03-26

Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-03-26 Common Stock M 65000 $5.51 Acquired 566898 Direct
2013-03-26 Common Stock F 51982 $6.89 Disposed 514916 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-03-26 Stock Option (Right to Buy) $5.51 M 65000 Disposed 2013-04-23 Common Stock (65000) Direct

Footnotes

F1: Payment made via forfeiture of 51,982 shares of Common Stock valued at the Closing Price of $6.89 on March 26, 2013.